MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin
Yubo Yan(Xidian University), Shidong Xu(Harbin Medical University)
Cited by 14
Related Papers
circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma
|Cell Death and Disease|2020|388
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer
|Oncotarget|2017|50
International expert consensus on the management of bleeding during VATS lung surgery
|Annals of Translational Medicine|2019|42
Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer
|OncoTargets and Therapy|2016|0